Astellas touts data from early test of stem cell-derived eye therapynews2026-05-07T22:13:30+00:00May 7th, 2026|Endpoints News|
Amazon adds Ozempic pill to same-day prescription drug kiosksnews2026-05-07T17:15:46+00:00May 7th, 2026|Endpoints News|
EnGene’s shares crash on updated pivotal bladder cancer datanews2026-05-07T15:44:27+00:00May 7th, 2026|Endpoints News|
Are health insurers out of the woods after a tough 2025?news2026-05-07T15:41:31+00:00May 7th, 2026|Endpoints News|
Blackstone puts $250M into Anagram to tackle cystic fibrosis complicationnews2026-05-07T15:31:33+00:00May 7th, 2026|Endpoints News|
Entrada stock falls on Duchenne data; Wegovy expands accessnews2026-05-07T15:04:25+00:00May 7th, 2026|Endpoints News|
Amgen adds $300M to Puerto Rico budget; Novartis to exit oral drug factory in Germanynews2026-05-07T14:00:58+00:00May 7th, 2026|Endpoints News|
Atara, Pierre Fabre’s cell therapy to get another shot at FDA approvalnews2026-05-07T13:17:55+00:00May 7th, 2026|Endpoints News|
Pennsylvania sues AI chatbot company for posing as a licensed doctornews2026-05-07T12:30:40+00:00May 7th, 2026|Endpoints News|
Angelini fortifies neurology portfolio with $4.1B buyout of Catalystnews2026-05-07T10:40:10+00:00May 7th, 2026|Endpoints News|
